Cerus Corporation

General ticker "CERS" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $332.2M (TTM average)

Cerus Corporation follows the US Stock Market performance with the rate: 16.3%.

Estimated limits based on current volatility of 2.3%: low 1.29$, high 1.35$

Factors to consider:

  • US accounted for 61.6% of revenue in the fiscal year ended 2024-12-31

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.36$, 2.74$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.29$, 2.59$]

Financial Metrics affecting the CERS estimates:

  • Negative: Non-GAAP EPS, $ of -0.11 <= 0.04
  • Negative: negative Operating income
  • Positive: 22.52 < Shareholder equity ratio, % of 27.94 <= 43.26
  • Positive: Industry inventory ratio change (median), % of -0.37 <= -0.28
  • Negative: Industry earnings per price (median), % of -5.82 <= 0
  • Positive: Interest expense per share, $ of 0.05 <= 0.10
  • Positive: 1.79 < Operating cash flow per share per price, % of 3.55

Similar symbols

Short-term CERS quotes

2025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-021.11.21.31.41.51.6
Price $

Long-term CERS plot with estimates

1.522.533.5Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.04−0.020
CERSS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $162.05MM $156.37MM $180.27MM
Operating Expenses $196.13MM $186.42MM $194.50MM
Operating Income $-34.08MM $-30.05MM $-14.22MM
Non-Operating Income $-8.26MM $-7.27MM $-6.53MM
Interest Expense $5.83MM $8.39MM $8.88MM
R&D Expense $64.11MM $67.64MM $58.91MM
Income(Loss) $-42.34MM $-37.32MM $-20.76MM
Taxes $0.49MM $0.33MM $0.20MM
Profit(Loss)* $-42.78MM $-37.49MM $-20.92MM
Stockholders Equity $67.61MM $52.65MM $56.15MM
Inventory $29.00MM $39.87MM $38.15MM
Assets $218.09MM $197.75MM $200.92MM
Operating Cash Flow $-25.61MM $-43.17MM $11.36MM
Capital expenditure $2.00MM $4.60MM $2.84MM
Investing Cash Flow $8.46MM $8.62MM $-8.13MM
Financing Cash Flow $4.19MM $10.67MM $4.96MM
Earnings Per Share** $-0.24 $-0.21 $-0.11

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.